• 제목/요약/키워드: PD cell

검색결과 450건 처리시간 0.026초

포켈스 소자를 이용한 PD 신호의 검출 및 비선형적 해석에 관한 연구 (A possible application of the PD detection technique using electro-optic Pockels cell with nonlinear characteristic analysis on the PD signals)

  • 임윤석;강원종;장용무;구자윤
    • 대한전기학회:학술대회논문집
    • /
    • 대한전기학회 2000년도 하계학술대회 논문집 C
    • /
    • pp.1850-1852
    • /
    • 2000
  • In this paper, new Partial Discharge (PD) detection technique using Pockels cell was proposed and considerable apparent chaotic characteristics were discussed. For this purpose, PD was generated from needle-plane electrode in air and detected by optical measuring system using Pockels cell, based on Mach-Zehnder interferometer, consisting of He-Ne laser, single mode optical fiber, 50/50 beam splitter and photo detector. A qualitative analysis was carried out by drawing Return map for the normalized time series of the detected PD signals. The results are as follows:(a) Fixed points, between 0.7 and 1.0, are appeared clearly in the right upper area of the return map as the increase in the number of obtained data.(b) Considerable periodicity have been remarked even though exact period and length can not be determined.(c) The self-similarity can be also observed inasmuch as the late paths do not follow the previous ones. Accordingly, exact quantitative analysis such as embedding dimension, fractal dimension, and Lyapunov exponents should be carried out for deducing the quantitative properties regarding PD phenomena.

  • PDF

Current understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity

  • Yadollahi, Pedram;Jeon, You-Kyoung;Ng, Wooi Loon;Choi, Inhak
    • BMB Reports
    • /
    • 제54권1호
    • /
    • pp.12-20
    • /
    • 2021
  • In the last decade, we have witnessed an unprecedented clinical success in cancer immunotherapies targeting the programmed cell-death ligand 1 (PD-L1) and programmed cell-death 1 (PD-1) pathway. Besides the fact that PD-L1 plays a key role in immune regulation in tumor microenvironment, recently a plethora of reports has suggested a new perspective of non-immunological functions of PD-L1 in the regulation of cancer intrinsic activities including mesenchymal transition, glucose and lipid metabolism, stemness, and autophagy. Here we review the current understanding on the regulation of expression and intrinsic protumoral activity of cancer-intrinsic PD-L1.

Human Embryonic Stem Cell Transplantation in Parkinson′s Disease (PD) Animal Model: II. In Vivo Transplantation in Normal or PD Rat Brain

  • Choe Gyeong-Hui;Ju Wan-Seok;Kim Yong-Sik;Kim Eun-Yeong;Park Se-Pil;Im Jin-Ho
    • 한국동물번식학회:학술대회논문집
    • /
    • 한국동물번식학회 2002년도 춘계학술발표대회 발표논문초록집
    • /
    • pp.19-19
    • /
    • 2002
  • This study was to examine whether the in vitro differentiated neural cells derived from human embryonic stem (hES, MB03) cells can be survived and expressed tyrosin hydroxylase(TH) in grafted normal or PD rat brain. To differentiate in vitro into neural cells, embryoid bodies (EB: for 5 days, without mitogen) were formed from hES cells, neural progenitor cells(neurosphere, for 7-10 days, 20 ng/㎖ of bFGF added N2 medium) were produced from EB, and then finally neurospheres were differentiated into mature neuron cells in N2 medium(without bFGF) for 2 weeks. In normal rat brain, neural progenitor cells or mature neuron cells (1×10/sup 7/ cells/㎖) were grafted to the striatum of normal rats. After 2 weeks, when the survival of grafted hES cells was examined by immunohistochemical analysis, the neural progenitor cell group indicated higher BrdU, NeuN+, MAP2+ and GFAP+ than mature neuron cell group in grafted sites of normal rats. This result demonstrated that the in vivo differentiation of grafted hES cells be increased simultaneously in both of neuronal and glial cell type. Also, neural progenitor cell grafted normal rats expressed more TH pattern than mature neuron cells. Based on this data, as a preliminary test, when the neural progenitor cells were grafted into the striatum of 6-hydroxydopamine lesioned PD rats, we confirmed the cell survival (by double staining of Nissl and NeuN) and TH expression. This result suggested that in vitro differentiated neural progenitor cells derived from hES cells are more usable than mature neuron cells for the neural cell grafting in animal model and those grafted cells were survived and expressed TH in normal or PD rat brain.

  • PDF

개미산 연료전지에서 연료극 팔라듐 촉매의 반응에 대한 연구 (A Study on Reactions of Palladium Anode Catalyst in Direct Formic Acid Fuel Cells)

  • 한종희;김진수;윤성필;남석우;임태훈;권용재
    • 공업화학
    • /
    • 제21권6호
    • /
    • pp.697-701
    • /
    • 2010
  • 팔라듐을 연료극 촉매로 이용한 개미산 연료전지에서의 성능과 팔라듐 촉매의 전기화학적 특성 분석을 수행하였다. 연구를 위해 사용된 팔라듐 촉매는 직접페인트법에 의해 제조되어 전해질 위에 코팅되었다. 개미산 연료전지를 연속적으로 반복 운행 했을 때, 팔라듐 촉매의 활성 및 개미산 연료전지의 분극 곡선 성능이 지속적으로 감소하였다. 이러한 거동은, 연료전지의 운행동안 팔라듐 촉매와 포매이트 및 수산화 이온간 전기화학적 반응에 의한 결합에 따른 팔라듐 촉매의 활성 저하 때문인 것으로 생각된다. 이러한 팔라듐 촉매의 활성 저하를 설명하고, 팔라듐 촉매와 개미산 연료전지의 활성을 되살리려는 실험이 선형 전압 인가법에 의해 수행되었다. 1.0볼트의 최대 전압을 가진 역방향 선형전압 인가 실험 후에 팔라듐 촉매의 활성 및 개미산 연료전지의 분극 곡선 성능이 되살아났다. 이는 역방향 선형 전압 인가법에 의해, 포매이트 및 수산화 이온들과의 결합되어 있던 팔라듐 촉매의 결합이 끊어지면서 팔라듐 촉매의 활성이 되살아났기 때문인 것으로 분석되었다.

팰래듐과 테루리움계의 상평형 연구 (Phase Constitution of the Palladium and Tellurium System)

  • 김원사
    • 한국결정학회지
    • /
    • 제1권2호
    • /
    • pp.66-75
    • /
    • 1990
  • Pd-Te계의 상평형도를 시차열분석, X선회절분석, 전자현미분석, 반사현미경을 사용해 연구하였다. 본 계의 0-50 at.%Te 부분의 새로운 상관계가 정립되었다. 본 계에는 Pd17Te4, Pd20Te7, Pd8Te3, Pd7Te3, PdgTe4, Pd3Te2, PdTe, PdTe2 등 8개의 화합물이 존재하며 이중 Pd17Te4와 Pd7Te3는 처음 보고되는 신종 화합물이다. Pd17Te4는 등축정계이며 공간군 Fd3r에 속하며 단위포 크기 (a)는 12. 678(5)차이다. PdaTe.4와Pd7Te3의 X선회절분말자료는 사방정계의 단위포 a=12.843(3), b=15.126(3), c=11.304(2)A와 단사 정계의 단위포 a=7.444(1), b=13.918(2), c=8.873 (2)il, β=92.46(2)에 의해 각각 격자지수화가 가능하였다. 본계에 존재하는 합성 화합물의 일부 물리적, 광학적 자료를 새로 보고하였다.

  • PDF

Re-defining T-Cell Exhaustion: Subset, Function, and Regulation

  • Se Jin Im;Sang-Jun Ha
    • IMMUNE NETWORK
    • /
    • 제20권1호
    • /
    • pp.2.1-2.19
    • /
    • 2020
  • Acute viral infection or vaccination generates highly functional memory CD8 T cells following the Ag resolution. In contrast, persistent antigenic stimulation in chronic viral infection and cancer leads to a state of T-cell dysfunction termed T-cell exhaustion. We and other have recently identified a novel subset of exhausted CD8 T cells that act as stem cells for maintaining virus-specific CD8 T cells in a mouse model of chronic lymphocytic choriomeningitis virus infection. This stem cell-like CD8 T-cell subset has been also observed in both mouse and human tumor models. Most importantly, in both chronic viral infection and tumor models, the proliferative burst of Ag-specific CD8 T cells driven by PD-1-directed immunotherapy comes exclusively from this stem cell-like CD8 T-cell subset. Therefore, a better understanding of the mechanisms how CD8 T-cell subsets are regulated during chronic viral infection and cancer is required to improve the current immunotherapies that restore the function of exhausted CD8 T cells. In this review, we discuss the differentiation of virus-specific CD8 T cells during chronic viral infection, the characteristics and function of CD8 T-cell subsets, and the therapeutic intervention of PD-1-directed immunotherapy in cancer.

폴리올 방법으로 합성된 팔라듐 촉매를 이용한 직접개미산연료전지에 대한 연구 (A Research on Direct Formic Acid Fuel Cell (DFAFC) using Palladium Catalyst Synthesized by Polyol Method)

  • 양종원;김의현;최미화;권용재
    • 한국수소및신에너지학회논문집
    • /
    • 제26권3호
    • /
    • pp.227-233
    • /
    • 2015
  • In this study, we evaluate catalytic activity of Pd/C catalyst that is synthesized by modified polyol method. With such formed Pd/C is used as anodic catalyst for direct formic acid fuel cell (DFAFC) and performances of the DFAFC are measured to verify whether the new catalyst is effective for enhancing DFAFC performance and to determine optimal loadings of the Pd/C needed for obtaining best DFAFC performance. Pd particle distribution of the Pd/C catalyst is analyzed by TEM, while its catalytic activity is estimated by using cyclic voltammogram (CV) as measuring formic acid oxidation reaction and active surface area. As a result of that, the Pd/C catalyst synthesized by modified polyol shows better catalytic activity and DFAFC performance with small loading amount of Pd/C. When loading amount of Pd/C is $1.5mgcm^{-2}$, maximum power density of DFAFC adopting the catalyst is $122mWcm^{-2}$.

Panaxadiol Arrests Cell Cycle by Elevating $p21^{WAF1/CIP1}$

  • Choi, Joon-Seok;Jin, Ying-Hua;Shin, Soon-A;Lee, Kwang-Yeol;Park, Jeong-Hill;Lee, Seung-Ki
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2-2
    • /
    • pp.168.1-168.1
    • /
    • 2003
  • We show that panaxadiol (PD), a ginseng saponin with a dammarane skeleton, selectively interferes with the cell cycle in human cancer cell lines. PD inhibited DNA synthesis in a dose-dependent manner with $IC_{50}$ values ranging from 0.8 $\mu$M-1.2 $\mu$M in SK-HEP-1 cells and HeLa cells. PD-treated cells were arrested at G1/S phase, shich coincided well with decreases in Cyclin A-Cdk2 activity, but not in Cyclin E-Cdk2 and Cdc2 activities. The intracellular levels of $p21^{WAF1/CIP1}$ were significantly and selectively elevated in a dose and time-dependent manners in PD-treated HeLa cells. (omitted)

  • PDF

Solar Cell을 응용한 배터리 없는 가시광 통신용 수신기 (Batteryless Receiver using Solar Cells for Visible Light Communication)

  • 정유진;신정민;한상규;사공석진
    • 전력전자학회:학술대회논문집
    • /
    • 전력전자학회 2017년도 전력전자학술대회
    • /
    • pp.66-67
    • /
    • 2017
  • 본 논문은 Solar Cell을 응용하여 통신기능과 함께 전원공급이 가능한 배터리 없는 가시광 통신용 수신기를 제안한다. 기존 포토다이오드(PD : Photo Diode)를 적용한 가시광 통신용 수신기는 수신신호 처리를 위한 PD 드라이버와 신호 처리부를 동작시키기 위하여 별도의 전원 회로와 배터리가 필요하다. 따라서, 체적 및 비용의 증가가 불가피하여 가시광 통신의 큰 문제점으로 대두되고 있다. 하지만 제안회로는 PD를 Solar Cell로 대체하여 기존의 신호를 수신함과 동시에 Solar Cell의 광전효과를 통해 생성된 전력을 사용하여 별도의 부가회로 없이 전원 공급이 가능하며 무선통신 기술의 새로운 패러다임을 제시한다. 제안된 회로의 타당성 검증을 위해 Solar Cell을 응용한 시작품을 제작하여 실험 결과를 제시한다.

  • PDF

Comparison of Radiological Tumor Response Based on iRECIST and RECIST 1.1 in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Programmed Cell Death-1 Inhibitor Therapy

  • Bingjie Zheng;Ji Hoon Shin;Hailiang Li;Yanqiong Chen;Yuan Guo;Meiyun Wang
    • Korean Journal of Radiology
    • /
    • 제22권3호
    • /
    • pp.366-375
    • /
    • 2021
  • Objective: To evaluate the radiological tumor response patterns and compare the response assessments based on immune-based therapeutics Response Evaluation Criteria in Solid Tumors (iRECIST) and RECIST 1.1 in metastatic clear-cell renal cell carcinoma (mccRCC) patients treated with programmed cell death-1 (PD-1) inhibitors. Materials and Methods: All mccRCC patients treated with PD-1 inhibitors at Henan Cancer Hospital, China, between January 2018 and April 2019, were retrospectively studied. A total of 30 mccRCC patients (20 males and 10 females; mean age, 55.6 years; age range, 37-79 years) were analyzed. The target lesions were quantified on consecutive CT scans during therapy using iRECIST and RECIST 1.1. The tumor growth rate was calculated before and after therapy initiation. The response patterns were analyzed, and the differences in tumor response assessments of the two criteria were compared. The intra- and inter-observer variabilities of iRECIST and RECIST 1.1 were also analyzed. Results: The objective response rate throughout therapy was 50% (95% confidence interval [CI]: 32.1-67.9) based on iRECIST and 30% (95% CI: 13.6-46.4) based on RECIST 1.1. The time-to-progression (TTP) based on iRECIST was longer than that based on RECIST 1.1 (median TTP: not reached vs. 170 days, p = 0.04). iRECIST and RECIST 1.1 were discordant in 8 cases, which were evaluated as immune-unconfirmed PD based on iRECIST and PD based on RECIST 1.1. Six patients (20%, 6/30) had pseudoprogression based on iRECIST, of which four demonstrated early pseudoprogression and two had delayed pseudoprogression. Significant differences in the tumor response assessments based on the two criteria were observed (p < 0.001). No patients demonstrated hyperprogression during the study period. Conclusion: Our study confirmed that the iRECIST criteria are more capable of capturing immune-related atypical responses during immunotherapy, whereas conventional RECIST 1.1 may underestimate the benefit of PD-1 inhibitors. Pseudoprogression is not rare in mccRCC patients during PD-1 inhibitor therapy, and it may last for more than the recommended maximum of 8 weeks, indicating a limitation of the current strategy for immune response monitoring.